Cargando…
Newly Designed Quinazolinone Derivatives as Novel Tyrosinase Inhibitor: Synthesis, Inhibitory Activity, and Mechanism
We synthesized a series of quinazolinone derivates as tyrosinase inhibitors and evaluated their inhibition constants. We synthesized 2-(2,6-dimethylhepta-1,5-dien-1-yl)quinazolin-4(3H)-one (Q1) from the natural citral. The concentration, which led to 50% activity loss of Q1, was 103 ± 2 μM (IC(50) =...
Autores principales: | Huang, Yaru, Yang, Jiefang, Chi, Yunyang, Gong, Chun, Yang, Haikuan, Zeng, Fanxin, Gao, Fang, Hua, Xiaoju, Wang, Zongde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457556/ https://www.ncbi.nlm.nih.gov/pubmed/36080324 http://dx.doi.org/10.3390/molecules27175558 |
Ejemplares similares
-
Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
por: Hashemi, Arshia, et al.
Publicado: (2023) -
Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity
por: Sonousi, Amr, et al.
Publicado: (2022) -
Monosubstituted Acetophenone Thiosemicarbazones as Potent Inhibitors of Tyrosinase: Synthesis, Inhibitory Studies, and Molecular Docking
por: Hałdys, Katarzyna, et al.
Publicado: (2021) -
“On-Water” Synthesis of Quinazolinones and Dihydroquinazolinones Starting from o-Bromobenzonitrile
por: Liu, Zibin, et al.
Publicado: (2018) -
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
por: Le, Yi, et al.
Publicado: (2020)